CTD Holdings, Inc.

Company Listings from SPi: CTD Holdings, Inc.

You are here: Home >> SPi Company Listings >> CTD Holdings, Inc.

 

CTD Holdings, Inc.

Website:
http://

Search for other references to "holdings" on SPi News

Latest CTD Holdings, Inc. News

CTD Holdings Announces Filing of Data From Expanded Access Program in Late Onset Alzheimer’s Disease in Support of Its Patent Application Filed In 2018 CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biopharmaceutical company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announc...... 13:00 GMT Tuesday 13th August 2019

CTD Holdings Submits Application for Listing on NASDAQ ALACHUA, FL, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based produ...... 17:53 GMT Wednesday 12th June 2019

CTD Holdings Announces Grant to U.S. Non-Profit Organization to Support Patient Participation in Informational Meetings with Regulators ALACHUA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treat...... 15:00 GMT Thursday 28th February 2019

CTD Announces Appointment of Sharon H. Hrynkow, PhD as Chief Scientific Officer ALACHUA, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treat...... 15:04 GMT Friday 15th February 2019

CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™ Provided Intravenously for Patients with Niemann-Pick Disease Type C ALACHUA, Fla., Feb. 07, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treat...... 13:00 GMT Thursday 7th February 2019

CTD Announces Partnership with United BioSource LLC (UBC) to support the Extension Protocol for its Phase I Clinical Trial in the United States ALACHUA, Fla., Jan. 18, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatm...... 13:00 GMT Friday 18th January 2019

CTD Announces Presentation at Upcoming Conference on Lysosomal Storage Diseases ALACHUA, Fla., Jan. 10, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatm...... 13:00 GMT Thursday 10th January 2019

CTD Holdings’ Senior VP for Medical Affairs Appointed to Committee of the National Academies of Sciences, Engineering, and Medicine ALACHUA, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treat...... 13:52 GMT Tuesday 8th January 2019

CTD Holdings Closes $2.0 Million Private Placement ALACHUA, Fla., Dec. 21, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatm...... 13:00 GMT Friday 21st December 2018

CTD Holdings to Present at WORLD Symposium on Lysosomal Storage Diseases ALACHUA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatm...... 13:00 GMT Wednesday 12th December 2018

Buy CTD Holdings, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us